Friday, July 10, 2026

pharma · Acquired Blepharoptosis · Diabetic Macular Edema

Santen Oy

News and analysis for Santen Oy on NovaPharmaNews — regulatory, clinical, and market coverage.

TAMPERE, FI HQ
15 Employees
EMA registrant Type
Company details
Status
Public
HQ
TAMPERE, FI
Employees
15
Programs
3
Drugs
8
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Santen Oy — regulatory, clinical, and market coverage.

News and analysis for Santen Oy on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Santen Oy yet.

Back to company overview →